Literature DB >> 14615027

Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [35S]GTPgammaS binding.

Janice L Shaw1, Susan L Gackenheimer, Donald R Gehlert.   

Abstract

Neuropeptide Y, one of the most abundant brain peptides, has been found to modulate several important biological functions via a family of G-protein coupled receptors. To investigate the localization of functional NPY receptor subtypes in the rat brain, we performed agonist-induced [35S]GTPgammaS autoradiography. The Y1/Y4/Y5 agonist Leu(31), Pro(34)-NPY increased [35S]GTPgammaS binding in several brain areas with a regional distribution consistent with that produced when labeling adjacent sections with [125I]-Leu(31), Pro(34)-PYY. The Y1 selective antagonist BIBP3226 antagonized the Leu(31), Pro(34)-NPY stimulated increase in [35S]GTPgammaS binding in all areas examined. The Y2 agonist C2-NPY stimulated [35S]GTPgamma binding in numerous brain areas with a regional distribution similar to the binding observed with [125I]-PYY 3-36. No increase in [35S]GTPgammaS binding above basal was observed in any brain area evaluated using Y4 and Y5 selective agonists. This study demonstrates abundant Y1 and Y2 receptor activation in the rat brain, while evidence for functional Y4 and Y5 receptors was not observed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615027     DOI: 10.1016/j.jchemneu.2003.07.003

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  7 in total

1.  Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease.

Authors:  Brian Spencer; Rewati Potkar; Jeff Metcalf; Ivy Thrin; Anthony Adame; Edward Rockenstein; Eliezer Masliah
Journal:  J Biol Chem       Date:  2015-11-30       Impact factor: 5.157

2.  Distribution of NPY Y5-like immunoreactivity in the rat brain.

Authors:  S Michelle Morin; Donald R Gehlert
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  PYY(3-36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of rats.

Authors:  J E Blevins; P K Chelikani; A C Haver; R D Reidelberger
Journal:  Peptides       Date:  2007-11-17       Impact factor: 3.750

Review 4.  G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasis.

Authors:  Georgina G J Hazell; Charles C Hindmarch; George R Pope; James A Roper; Stafford L Lightman; David Murphy; Anne-Marie O'Carroll; Stephen J Lolait
Journal:  Front Neuroendocrinol       Date:  2011-07-23       Impact factor: 8.606

5.  Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis.

Authors:  Brandon T Milliken; Clinton Elfers; Oleg G Chepurny; Kylie S Chichura; Ian R Sweet; Tito Borner; Matthew R Hayes; Bart C De Jonghe; George G Holz; Christian L Roth; Robert P Doyle
Journal:  J Med Chem       Date:  2021-01-15       Impact factor: 7.446

6.  Maternal Treatment with Metformin Persistently Ameliorates High-Fat Diet-Induced Metabolic Symptoms and Modulates Gut Microbiota in Rat Offspring.

Authors:  Lin Song; Jiaqi Cui; Shuyuan Hu; Rui Wang; Hongbao Li; Bo Sun
Journal:  Nutrients       Date:  2022-09-01       Impact factor: 6.706

Review 7.  Ligands of the Neuropeptide Y Y2 Receptors as a Potential Multitarget Therapeutic Approach for the Protection of the Neurovascular Unit Against Acute Ischemia/Reperfusion: View from the Perspective of the Laboratory Bench.

Authors:  Łukasz Przykaza; Ewa Kozniewska
Journal:  Transl Stroke Res       Date:  2021-07-22       Impact factor: 6.829

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.